Both in Pharmaceuticals
Xeris Biopharma Holdings vs SELLAS Life Sciences Group
Over the past year XERS returned +4.5% and SLS returned +395.5%; their daily moves had a correlation of 0.16.
XERS +4.5% SLS +395.5%Growth of $1, one year, split-adjusted
| Metric | XERS | SLS |
|---|---|---|
| Price | $10.35 | $8.87 |
| Market cap | $1.89B | $1.79B |
| Today | +1.77% | +3.74% |
| 1 month | +2.2% | −23.7% |
| 6 months | +66.1% | +82.1% |
| Year to date | +31.8% | +135.3% |
| 1 year | +6.7% | +387.4% |
| Revenue growth (YoY) | +28.7% | — |
| Gross margin | 86.4% | — |
| Net margin | −33.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 5.6× | — |
| Net cash | -$130.8M | $138.3M |
| Dividend yield | — | — |
| Volatility (60d) | 52.4% | 96.8% |
| Short % of float | 4.6% | 27.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).